ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

The Role of Nab-Paclitaxel in Treating TNBC

Denise Yardley, MD
Published Online:7:48 PM, Wed May 10, 2017

Denise Yardley, MD, senior investigator at the Sarah Cannon Research Institute, discusses the role of nab-paclitaxel (Abraxane) in the treatment of triple-negative breast cancer (TNBC). 
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.